Remuneration Information • Apr 8, 2025
Remuneration Information
Open in ViewerOpens in native device viewer


WIIT SpA Share capital €2,802,066 fully paid-in Tel: +39 02 36607500 Registered Office and Headquarters Tax Code/VAT Number: 01615150214 Fax: +39 03 36607505

| "Executive Directors" | WIT's Executive Directors in office at the time. | |
|---|---|---|
| "Shareholders' Meeting" | WIT's Ordinary or Extraordinary Shareholders' Meeting. | |
| "Shares" | WII I 's no-par value common stock listed on the Euronext Market (EXM). |
|
| "Civil Code" | Royal Decree No. 262 of March 16, 1942, as amended and supplemented. |
|
| "Corporate Code" |
Governance The Italian Stock Exchange (Borsa Italiana S.p.A.) Corporate Governance Committee's Corporate Governance Code for listed companies, in effect at the Report Date, and made available at www.borsaitaliana.it |
|
| "Board of Auditors" |
Statutory The Board of Statutory Auditors of WIT in office at the time. |
|
| "Appointments Remuneration Committee" |
and The "Appointments and Remuneration Committee" of WIIT in office at the time. |
|
| "Board of Directors" | The Board of Directors of WIIT in office at the time. | |
| "Chief Executive Officer" | The Chief Executive Officer of WIJT in office at the time. | |
| "Consob" | Commissione Nazionale per le Società e la Borsa (Italian market oversight authority). |
|
| "Report Date" | March 11, 2025. | |
| "Senior Executives" | The parties defined as such in the Annex to the Consob Related Party Transactions (RPT) Regulation. |
|
| EBIT" | "Adjusted Consolidated The adjusted consolidated EBIT value of the Group as per the consolidated financial statements approved by the Board of Directors of the Company for the reference year. The Adjusted Consolidated EBIT does not account for any costs relating to the variable remuneration of Executive Directors accrued or paid in the reporting year. |
|
| "Adjusted Target EBIT" | The adjusted consolidated EBIT value of the Group to be achieved in each reference year, defined by the Board of Directors as part of the year's annual budget, to which the set aside costs relating to the variable remuneration of the Executive Directors is added. In the event of Group transactions involving the acquisition or sale of equity investments, companies, or business units, WII I's Board of Directors may modify the reference year's Adjusted |

Target EBIT to account for them.


This Remuneration Report is prepared pursuant to Article 123-ter of the CFA and Article 84quater of the Issuers' Regulation.
The Report was approved by the Board of Directors on March 11, 2025, upon the proposal of the Appointments and Remuneration Committee. It is divided into two Sections, drafted in accordance with Annex 3A, Schedule 7-bis, of the Issuers' Regulation.
Section I of the Report provides information on WIIT's policy for the remuneration of members of the Administration Boards, Senior Executives and members of the control bodies, in addition to the procedures used to adopt and apply this policy. Taking into account the organizational structure of the Company, the Issuer has identified three Senior Executives as at the Report Date (of whom one is a Non-Executive Director).
Section II of the Report sets out the individual items that make up the remuneration of the Company's Directors, Senior Executives and Statutory Auditors, and provides an analytical summary of the remuneration paid to these individuals in 2024 for any reason and in any form by the Company and any subsidiaries or affiliates.

The preparation, approval and implementation of the Remuneration Policy involves the following bodies and individuals, each to the extent within its remit:
The Board of Directors, upon the proposal of the Appointments and Remuneration Committee, defines and adopts the Remuneration Policy. After examining and approving the Remuneration Policy, the Board of Directors submits this to the binding vote of the Shareholders' Meeting, making it available at least 21 days before the date of the Shareholders' Meeting through the publication of the Remuneration Policy and Report.
The Remuneration Policy was reviewed by the Appointments and Remuneration Committee on March 5, 2025, and subsequently approved by the Board of Directors on March 11, 2025.
This Section I - prepared as per Article 123-ter, Paragraph 3, of the CFA - will be submitted for approval by the Shareholders' Meeting scheduled for April 29, 2025, as per Article 123-ter, Paragraph 3-bis, of the CFA.
Should the Shareholders' Meeting not approve the Remuneration Policy submitted for a vote pursuant to Article 123, paragraph 3-bis of the CFA, WIIT will continue to pay remuneration in accordance with the remuneration policy most recently approved by the Shareholders' Meeting. In this event, WIT shall submit a new Remuneration Policy to a vote of the shareholders, at the latest at the next Shareholders' Meeting provided for in Article 2364, paragraph 2, of the Civil Code.
****
As noted above, the definition of WIIT's Remuneration Policy is entrusted to the Board of Directors, which makes use of the advisory and proposal-making activities of the Appointments and Remuneration Committee.
The Board of Directors resolves on the following matters:

For information on the Appointments and Remuneration Committee, please refer to paragraph 2 of Section I of this Report.
The Shareholders' Meeting:
Pursuant to Article 2389, paragraph 3 of the Civil Code, the Board of Statutory Auditors expresses its opinion on proposals for the remuneration of Senior Directors, where not already established by the Shareholders' Meeting.
The independent audit firm verifies the Directors' preparation of Section II of the Report, as required by Article 123-ter, paragraph 8-bis of the CFA.
At the Report Date, as appointed by the Board of Directors on May 16, 2024, the Appointments and Remuneration Committee is composed of the following members:

On March 11, 2025, and on the basis of the information provided by the interested parties and that available to the Company, the Board of Directors assessed and declared the meeting of the independence requirements as per Article 148, paragraph 3 of the CFA, as referred to an Article 147-ter, paragraph 4 of the CFA, in addition to the Corporate Governance Code, of the aforementioned Directors.
The Board of Directors assessed that Enrico Giacomelli, as member of the Appointments and Remuneration Committee, possessed adequate knowledge and expertise in financial matters, considering his over twenty years of experience in managerial roles.
In support of the Board of Directors, the Appointments and Remuneration Committee is entrusted with the following tasks:
The Remuneration Report was prepared without the involvement of independent experts.
In applying to certain figures and their roles, while the Remuneration Policy does not explicitly

consider the non-comparable remuneration and working conditions of the Company's general employees, it uses the same tools and logic as applied to the entire company population, targeted at attracting, motivating and retaining people with the professional qualities to contribute to the growth and promotion of the long-term interests and sustainability of the Company and the Group.
In particular, the remuneration of almost all the Company's employees includes an annual variable component payable on the basis of the achievement of specific performance targets, as identified by the heads of the various corporate departments. We also note that, with reference to the medium- to long-term variable component for employees of WIIT and other Group companies, that:

Finally, regarding non-monetary benefits, on November 13, 2023, the Board of Directors approved the Welfare Plan, applying to not only Executive Directors and Senior Executives, but also all other managerial figures, in addition to 18 and 200 level employees. In this regard, we note that the Welfare Plan provides the same non-monetary benefits to all recipients, differentiated only in terms of the amounts applied to respective categories.
In accordance with the law, the Remuneration Policy has a maximum duration of three financial years, without prejudice to the Board of Directors' right to submit to the Shareholders' Meeting a new Remuneration Policy and/or any changes it deems appropriate during that period.
The WIIT Group's key personnel remuneration system is targeted at attracting, motivating and retaining key resources, at aligning the interests of key personnel with those of shareholders, and at creating a strong link between remuneration and WIIT Group performance.
Through the Remuneration Policy, WIIT pursues the following objectives:
In order to achieve these objectives in line with general principles, it is envisaged that:
As regards the changes from the Remuneration Policy contained in the 2024 Remuneration Report, we note:
a change to the MBO (as defined below) for Senior Executives. Specifically, (i) the Component linked to Group targets was supplemented by providing for EBIT in addition to EBITDA, and (ii) a stand-alone ESG Component was introduced (previously provided for in the Remuneration Policy contained in the 2024 Remuneration Report in the Function Targets Component). This results in a change in the weighting of the individual

Components in relation to the overall MBO value;
Finally, the Remuneration Policy contained in the 2024 Remuneration Report was approved by the Shareholders' Meeting on May 16, 2024. Votes in favor totaled 70.150795% of the total voting rights and 89.347716% of the total voting rights present. No questions and/or comments in relation to the Remuneration Policy were received from parties entitled to attend before or during the Shareholders' Meeting pursuant to Article 127-ter of the CFA.
In line with the provisions of Section I, paragraph 1.5 of this Report, the main components of the remuneration of the Executive Directors are as follows:
Specifically, on the basis of the remuneration allocated to individual Executive Directors, the variable component (including the annualized medium- to long-term component), in its maximum amount, accounts for between 62% and 79% of the total annual monetary remuneration.
The main components of the remuneration of the Chairperson of the Board of Directors are as follows:
The main components of the remuneration of Non-Executive Directors are as follows:

As per law and the By-Laws, the remuneration of Supervisory Board members is set by the Shareholders' Meeting on appointment for the entire duration of office. There are no variable remuneration components.
The main components of the remuneration of Senior Executives are as follows:
In particular, we note that, on the basis of the remuneration allocated to individual Senior Executives, the variable component, in its maximum amount, accounts for between 15% and 48% of the total annual monetary remuneration.
All Directors and Statutory Auditors are recipients of a liability policy (D&O insurance).
Executive Directors, on a case by case basis, as determined by the Board of Directors of, may be assigned: (i) a company car for mixed use; (ii) an insurance policy with a leading insurance company covering life, death, permanent disability and injuries, including due to illness, with a survivor's benefit in favor of the Director's family; (iii) a reimbursement health insurance policy, including a complete annual check-up and dental and specialist expenses, with a leading healthcare company, with coverage of no less than 70% of the expenses for the Director and the Director's family members; (iv) reimbursement of school expenses up to a maximum of Euro 75,000 per year; (v) housing expenses for residential use in Milan, where the Company is based, up to a maximum of Euro 60,000 per year.
Senior Executives, on a case by case basis, as determined by the competent bodies, may be assigned: (i) a company car for mixed use; (ii) an insurance policy in accordance with national collective bargaining agreement contracts covering permanent disability and injuries, including due to illness, with a survivor's benefit in favor of the Executive's family; (iii) a reimbursement health insurance policy, including an annual check-up and dental and specialist expenses, as envisaged under the "Marketing Managers" National Collective Bargaining Agreement; (iv) base welfare as per the company plan for Euro 4,000 per year; (v) housing expenses for residential use in Milan, where the Company is based, up to a maximum

of Euro 25,000 per year.
An annual monetary variable Management by Objectives (for the purposes of this subparagraph, "MBO") remuneration is envisaged for each Executive Director on achieving specific performance targets (for the purposes of this sub-paragraph, the "MBO Performance Targets"), as indicated below.
The maximum MBO payable to each of the Executive Directors is Euro 300,000, on achievement of all MBO Performance Targets (for the purposes of this sub-paragraph, the "Maximum Amount").
Performance Targets and assessment of their achievement
MBO Performance Targets and assessment of their achievement for the Chief Executive Officer
The MBO amount is divided into two components (Component A, and Component B), to which the Chief Executive Officer will be entitled on the basis of the achievement of the relevant MBO Performance Targets, as per the following tables.
"Component A" is here given to mean an amount equal to 50% of the Maximum Amount.
The Chief Executive Officer accrues the right to the payment of Component A on the basis of the value of the Adjusted Consolidated EBITDA compared to the Adjusted Target EBITDA, as per the following table:
| Adjusted Consolidated EBITDA | Component A amount to be allocated |
|---|---|
| Equal to or Greater than 100% of the 100% Adjusted Target EBITDA |
|
| 95% of the Adjusted Target EBITDA | 80% |
| Less than 90% of the Adjusted Target 0% EBITDA |
For each financial year, the achievement of the MBO Performance Target will be verified, and the Component A amount calculated, on the basis of the Adjusted Consolidated EBITDA compared to the Adjusted Target EBITDA, on approval of the consolidated financial statements for the year by the Board of Directors.
When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.

"Component B" is here given to mean an amount equal to 50% of the Maximum Amount.
The Chief Executive Officer accrues the right to the payment of Component B on the basis of the value of the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, as per the following table:
| Adjusted Consolidated EBIT | Component B amount to be allocated |
|---|---|
| Equal to or greater than 100% of the 100% Adjusted Target EBIT |
|
| 95% of the Adjusted Target EBIT | 80% |
| Less than 90% of the Adjusted Target EBIT 0% |
For each year, the achievement of the MBO Performance Target will be verified, and the Component B amount calculated, on the basis of the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, on approval of the consolidated financial statements for the year by the Board of Directors.
When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.
***
The Chief Executive Officer may not obtain an MBO in any amount greater than the Maximum Amount. In order to incentivize achievement of the Maximum Amount, if one component's performance target is exceeded, the excess may be allocated to the MBO, to make up for the other component not reaching 100% of its targets, up to, in any case, the limit of the Maximum Amount.
MBO Performance Targets and assessment of their achievement for Executive Directors, excluding the Chief Executive Officer
The MBO amount is divided into three components (Component A, Component B, and Component C), to which the Executive Directors (excluding the Chief Executive Officer) will be entitled on the basis of the achievement of their MBO Performance Targets, as per the proportions indicated below.
"Component A" is here given to mean an amount equal, depending on the case, to 40% or to one third of the Maximum Amount.
The Executive Directors accrue the right to the payment of Component A upon achievement of specific personal Performance Targets voted on by the Board of Directors, excluding the interested party.
Specifically, for (i) the Chief Merger & Acquisition Officer, the targets relate to scouting targets and negotiating for the purpose of acquisition transactions, and (ii) for the Chief Sales Officer, the targets relate to booking contracts.

For each financial year, the achievement of the MBO Performance Target will be verified, and the Component A amount calculated, on approval, by the Board of Directors, of the consolidated financial statements for the year.
"Component B" is here given to mean an amount equal, depending on the case, to 30% or to one third of the Maximum Amount.
The Executive Directors accrue the right to the payment of Component B on the basis of the value of the Adjusted Consolidated EBITDA compared to the value of the Adjusted Target EBITDA, as per the following table:
| Adjusted Consolidated EBITDA | Component B amount to be allocated |
|---|---|
| Equal to or Greater than 100% of the 100% Adjusted Target EBITDA |
|
| 95% of the Adjusted Target EBITDA | 80% |
| Less than 90% of the Adjusted Target 0% EBITDA |
For each financial year, the achievement of the MBO Performance Target will be verified, and the Component B amount calculated, on the basis of the Adjusted Consolidated EBITDA compared to the Adjusted Target EBITDA, on approval of the consolidated financial statements for the year by the Board of Directors.
When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.
"Component C" is here given to mean an amount equal, depending on the case, to 30% or to one third of the Maximum Amount.
The Executive Directors accrue the right to the payment of Component C on the basis of the value of the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, as per the following table:
| Adjusted Consolidated EBIT | Component C amount to be allocated |
|---|---|
| Equal to or greater than 100% of the 100% Adjusted Target EBIT |
|
| 95% of the Adjusted Target EBIT | 80% |
| Less than 90% of the Adjusted Target EBIT 0% |
For each financial year, the achievement of the MBO Performance Target will be verified, and the Component C amount calculated, on the basis of the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, on approval of the consolidated financial statements for the year by the Board of Directors.

When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.
* *
Beneficiaries may not obtain an MBO in any amount greater than the Maximum Amount. In order to incentivize achievement of the Maximum Amount, if one component's performance target is exceeded, the excess may be allocated to the MBO, to make up for other Components not reaching 100% of their targets, up to, in any case, the limit of the Maximum Amount.
The MBO accrued will be paid on approval of the consolidated financial statements for the relevant financial year by the Board of Directors.
No deferred payment systems or ex-post correction mechanisms are envisaged.
On March 12, 2024, WIT's Board of Directors, on the proposal of the Appointments and Remuneration Committee, approved a medium to long-term monetary incentive plan, for the three-year period 2024-2025, entitled the "2024-2026 Long-Term Incentive Plan" (also the "2024-2026 LTI Plan"), and reserved for the individuals identified by the Board of Directors from among WIT's Executive Directors, on the proposal of the Appointments and Remuneration Committee.
The part of the 2024-2026 LTI Plan also based on the performance of WIIT stock was approved, as per Article 114-bis of the CFA, by the Shareholders' Meeting on May 16, 2024.
The incentive provided for in the 2024-2026 LTI Plan (the "LTI Bonus") is monetary in nature, with a total maximum amount set at Euro 1,764,000 for the three-year period 2024-2025-2026. The maximum LTI Bonus payable to each beneficiary under the plan, in the event of achievement of all the set Performance Targets, is equal to 30% of the sum (the "Maximum Amount") of: (i) the gross remuneration for the office of Director, as resolved by the Board of Directors, accrued by the beneficiary between January 1, 2024 and December 31, 2026, in addition to the remuneration accrued during the same period for offices held at other Group companies. With the cost relating to the Gross Annual Salary accrued by beneficiaries that are also employees of the Company between January 1, 2024 and December 31, 2026 added to the aforementioned amount; and (ii) the annual variable monetary remuneration linked to the achievement of the short-term targets (MBOs) accrued by the beneficiary between January 1, 2024 and December 31, 2026.
The beneficiaries of the 2024-2026 LTI Plan were identified by the Board of Directors, upon the proposal of the Appointments and Remuneration Committee, in the persons of Alessandro Cozzi, Francesco Baroncelli and Enrico Rampin.
Performance Targets and assessment of their achievement
Each beneficiary is entitled to the payment of the allocated LTI Bonus provided that the specific performance targets (the "LTI Performance Targets") related to the economic and financial results of WIIT Group are achieved, as per the proportions below.

In particular, the LTI Bonus is divided into three components (Component A, Component B, and Component C), to which the beneficiaries will be entitled on the basis of the achievement of the relevant LTI Performance Targets, as per the proportions indicated below.
"Component A" is here given to mean an amount equal to 50% of the Maximum Amount, except as indicated below.
The beneficiary accrues the right to the payment of Component A on the basis of the socalled Volume Weighted Average Price (VWAP) of the WIIT share referring to the period between September 1, 2026 and November 30, 2026 (inclusive), as per the following table:
| VWAP | Component A amount to be allocated |
|---|---|
| Equal to or Greater than Euro 40 | 120% |
| Euro 38 | 100% |
| Euro 34 | 50% |
| Euro 30 | 20% |
| Less than Euro 30 | 0% |
In the event of the revocation of the Shares from listing and trading on the EXM (the "Delisting"), the beneficiaries, from and including the year of the Delisting, will no longer be entitled to the payment of Component A. In this case, again from and including the year of the Delisting, both Components B and C will be proportionally increased in terms of the percentage of the Residual Amount (as defined below).
"Component B" is here given to mean an amount equal to 25% of the Maximum Amount, except as indicated below.
The beneficiaries accrue the right to the payment B on the basis of the value of the Adjusted Consolidated EBITDA compared to the Adjusted Target EBITDA, as per the following table:
| Adjusted Consolidated EBITDA | Component B amount to be allocated |
|---|---|
| Equal to or greater than 110% of the 130% Adjusted Target EBITDA |
|
| 100% of the Adjusted Target EBITDA | 100% |
| 95% of the Adjusted Target EBITDA | 35% |
| Less than 90% of the Adjusted Target 0% FBITDA |

The achievement of the Performance Target will be verified, and the Component B amount calculated, on the basis of the average of the percentage ratio of the Adjusted Consolidated EBITDA to the Adjusted Target EBITDA, for each of the reference years (2024-2025-2026), it being understood that the right of the beneficiaries to receive Component B is in any case dependent on the value of the Adjusted Consolidated EBITDA relating to the last year considered (i.e. the Adjusted Consolidated EBITDA for the year ending December 31, 2026) being equal to at least 95% of the Adjusted Target EBITDA.
"Component C" is here given to mean an amount equal to 25% of the Maximum Amount, except as indicated below.
The beneficiaries accrue the right to payment of Component C on the basis of the value of the Adjusted Consolidated EBIT compared to the value of the Adjusted Target EBIT, as per the following table:
| Adjusted Consolidated EBIT | Component C amount to be allocated |
|---|---|
| Equal to or greater than 110% of the 130% Adjusted Target EBIT |
|
| 100% of the Adjusted Target EBIT | 100% |
| 95% of the Adjusted Target EBIT | 35% |
| Less than 90% of the Adjusted Target EBIT | 1 0% |
The achievement of the Performance Target will be verified, and the Component C amount calculated, on the basis of the average of the percentage ratio of the Adjusted Consolidated EBIT to the Adjusted Target EBIT, for each of the reference years (2024-2025-2026), it being understood that the right of the beneficiaries to receive Component C is in any case dependent on the value of the Adjusted Consolidated EBIT relating to the last year considered (i.e. the Adjusted Consolidated EBT for the year ending December 31, 2026) being equal to at least 95% of the Adjusted Target EBIT.
When intermediate values are achieved with respect to those indicated, the LTI Bonus amount will be determined by applying the linear interpolation method.
Beneficiaries may not obtain an LTI Bonus in any amount greater than the Maximum Amount. In order to incentivize achievement of the Maximum Amount, if one Component's performance target is exceeded, the excess may be allocated to the LTI Bonus, to make up for other Components not reaching 100% of their targets, up to, in any case, the limit of the Maximum Amount.
We note that in the event of Delisting, the beneficiaries will be entitled to the payment of Component A of the LTI Bonus as indicated below. Specifically, the beneficiaries will obtain the right to payment of Component A: (a) in the event of Delisting, following completion of a public tender offer purchase or exchange of the Shares, on the basis of the offer price (the "Offer Price"); or (b) in the event of Delisting other than as indicated in (a) above, on the basis

of the Volume Weighted Average Price (VWAP) of the WIIT share in the 60 days (inclusive) prior to the Delisting, as indicated below:
| Offer Price/VWAP | Component A amount to be allocated |
|---|---|
| Equal to or Greater than Euro 40 | 120% |
| Euro 38 | 100% |
| Euro 34 | 50% |
| Euro 30 | 20% |
| Less than Euro 30 | 0% |
The amount of Component A to be attributed, as calculated above, will be reduced by applying a pro rata temporis criterion taking into account exclusively the period prior to the Delisting.
Any positive difference (the "Residual Amount") between x, the maximum amount of Component A that can be attributed, and y, the attributed Component A, will be proportionally divided in percentage terms between Component B and Component C in equal parts, up to the limit of the Maximum Amount.
Any LTI Bonus accrued will be paid to the beneficiaries by June 30, 2027, following approval of the consolidated financial statements by the WIIT Board of Directors for the year ending December 31, 2026.
In the event that within 3 years from the date of payment of the LTI Bonus, there is evidence that such an LTI Bonus has been paid on the basis of incorrect or false data, resulting from illicit or grossly negligent conduct by one or more beneficiaries, the Board of Directors will have the right to demand from the beneficiaries, and the beneficiaries will have the obligation, to return the full amount of the LTI Bonus to the Company, without prejudice to any other rights, actions or remedies available to the Company. Such a return obligation shall remain effective even in the event of termination of the beneficiary's relationship with the Company.
On March 19, 2021, WIT's Board of Directors, on the proposal of the Appointments and Remuneration Committee, approved an incentive plan entitled the "2021-2026 Stock Option Plan" (the "2021-2026 Stock Option Plan") reserved to individuals to be identified by the Board, under advisory from the Appointments and Remuneration Committee, from among the Executive Directors and Senior Executives of WIT and of the other companies of WIIT Group. The 2021-2026 Stock Option Plan was approved, as per Article 114-bis of the CFA, by the Shareholders' Meeting on May 5, 2021().
This plan provides for the grant to the beneficiaries of stock options (for the purposes of this
(1) We note that on May 13, 2021, with the approval of the Shareholders' Meeting of May 5, 2021, the Board of Directors resolved to amend the 2021-2026 Stock Option Plan to account for the implementation of the 1:10 split in WIT Shares, while keeping the substantial and economic contents of the plan unchanged.

sub-paragraph, the "Options"), which give the beneficiaries the right to receive Shares in the Company's portfolio through the exercising of the Options, in the ratio of 1 Share for each Option exercised. Specifically, the 2021-2026 Stock Option Plan provides for the grant of a maximum of 1,000,000 Options, valid for the allocation of a maximum of 1,000,000 Treasury Shares of the Company.
The granting and exercise of Options are not contingent on achieving performance targets.
Options may be exercised by beneficiaries in whole or in part:
Beneficiaries permanently lose the right to exercise the Options if within 12 months from the date of approval of the 2021-2026 Stock Option Plan by the Shareholders' Meeting, as per Article 114-bis of the CFA, that is, by May 5, 2022, one of the following events occurs:
After 12 months from the date of approval of the 2021-2026 Stock Option Plan by the Shareholders' Meeting, as per Article 114-bis of the CFA, that is, from May 5, 2022, the beneficiaries have the right to exercise the Options granted to them in advance of the dates indicated in the previous sub-paragraph "Exercise of the Options" (for the purposes of this sub-paragraph, the "Early Option Exercising Right"), if one of the following events occurs:

In the absence of a valid exercise of the Early Exercise Right pursuant to the terms and conditions set out for the exercise of the Options in the 2021-2026 Stock Option Plan regulation remain unchanged.
Without prejudice to that indicated in the previous sub-paragraph "Loss of the Option Exercising Right and the Early Option Exercising Right", in the event of:
Offer, where the relevant bidder(s) avail themselves of the right to purchase pursuant (i) to Article 111 of the CFA (for the purposes of this sub-paragraph, the "111 Purchase Right"), the beneficiaries may exercise the Options within and no later than 3 business days from the dissemination, pursuant to Articles 36 and 50-quinquies, paragraph 2, of the Issuers' Regulation, of the notice containing the information necessary for the exercise of the 111 Purchase Right by the bidder(s) (for the purposes of this subparagraph the "Public Offer Exercise").
In the absence of a valid Public Offer Exercise within the terms and according to the procedures set forth above, the beneficiaries will definitively lose the right to exercise the Options; or
(ii) resolution of a transaction resulting in the Delisting of the Shares from trading on the EXM (for the purposes of this sub-paragraph, the "Resolution"), the beneficiaries will be able to exercise the Options no later than 3 working days from the Resolution (for the purposes of this sub-paragraph, the "Delisting Exercise").
In the absence of a valid Delisting Exercise within the terms and according to the procedures set forth above, the beneficiaries will definitively lose the right to exercise the Options.
****
No ex-post correction mechanisms are envisaged.
On March 17, 2022, WIIT's Board of Directors, on the proposal of the Appointments and Remuneration Committee, approved an incentive plan entitled the "2022-2027 Stock Option Plan" (the "2022-2027 Stock Option Plan"), reserved to the Chairperson of the Board, in addition to Executive Directors, Senior Executives and Key Managers of the Group companies identified by the Board, under advisory from the Appointments and Remuneration Committee. The 2022-2027 Stock Option Plan was approved, as per Article 114bis of the CFA, by the Shareholders' Meeting on April 21, 2022.
This plan provides for the grant to the beneficiaries of stock options (for the purposes of this sub-paragraph, the "Options"), which give the beneficiaries the right to receive Shares in the Company's portfolio through the exercising of the Options, in the ratio of I Share for each Option exercised. Specifically, the 2022-2027 Stock Option Plan provides for the grant of a maximum of 250,000 Options, valid for the allocation of a maximum of 250,000 Treasury Shares of the Company.

The granting and exercise of Options are not contingent on achieving performance targets.
Rights accrual, deferred payment systems and ex-post correction mechanisms terms
Options may be exercised by beneficiaries in whole or in part from July 1, 2027.
After 12 months from the date of approval of the 2022-2027 Stock Option Plan by the Shareholders' Meeting, as per Article 114-bis of the beneficiaries have the right to exercise the Options granted to them in advance of the dates indicated in the previous subparagraph "Exercise of the Options" (for the purposes of this sub-paragraph, the "Early Option Exercising Right"), if one of the following events occurs:
In the absence of a valid exercise of the Early Exercise Right pursuant to the above, the terms and conditions set out for the exercise of the Options in the 2022-2027 Stock Option Plan regulation remain unchanged.
In the event of:
(iii) Offer, where the relevant bidder(s) avail themselves of the right to purchase pursuant to Article 111 of the CFA (for the purposes of this sub-paragraph, the "111 Purchase Right"), the beneficiaries may exercise the Options within and no later than 3 business days from the dissemination, pursuant to Articles 36 and 50-quinquies, paragraph 2, of the Issuers' Regulation, of the notice containing the information necessary for the exercise of the 111 Purchase Right by the bidder(s) (for the purposes of this subparagraph the "Public Offer Exercise").
In the absence of a valid Public Offer Exercise within the terms and according to the procedures set forth above, the beneficiaries will definitively lose the right to exercise the Options; or
(iv) resolution of a transaction resulting in the Delisting of the Shares from trading on the EXM (for the purposes of this sub-paragraph, the "Resolution"), the beneficiaries will be able to exercise the Options no later than 3 working days from the Resolution (for the purposes of this sub-paragraph, the "Delisting Exercise").
In the absence of a valid Delisting Exercise within the terms and according to the procedures set forth above, the beneficiaries will definitively lose the right to exercise the Options.

No ex-post correction mechanisms are envisaged.
An annual monetary variable Management by Objectives (for the purposes of this subparagraph, "MBO") remuneration is envisaged for each Senior Executive on achieving specific performance targets (for the purposes of this sub-paragraph, the "MBO Performance Targets"), as indicated below.
The maximum MBO payable to each of the Senior Executives is between Euro 20,000 and Euro 100,000, on achievement of all MBO Performance Targets (for the purposes of this subparagraph, the "Maximum Amount").
The MBO amount is divided into three components (Component A, Component B and Component C), to which the Senior Executive will be entitled on the basis of the achievement of the relevant MBO Performance Targets, as set out below.
"Component A" refers to an amount between 22% and 35% of the Maximum Amount, as appropriate.
The Senior Executives accrue the right to the payment of Component A upon achievement of one or more specific personal Performance Targets established by the Chief Executive Officer. Specifically, depending on the functions performed, the targets relate to (i) cost savings (opex), (ii) financial and non-financial reporting, and (iii) investment management (capex).
For each financial year, the achievement of the MBO Performance Target will be verified, and the Component A amount calculated, on approval, by the Board of Directors, of the consolidated financial statements for the year.
"Component B" refers to an amount between 40% and 70% of the Maximum Amount, as appropriate.
The Senior Executives accrue the right to the payment of up to 50% of Component B on the basis of the value of the Adjusted Consolidated EBITDA compared to the value of the Adjusted Target EBITDA, as per the following table:
| Adjusted Consolidated EBITDA | Component B amount to be allocated |
|---|---|
| Equal to or Greater than 100% of the 50% Adjusted Target EBITDA |
|
| Less than 95% of the Adjusted Target 0% EBITDA |

The Senior Executives accrue the right to the payment of up to 50% of Component B on the basis of the value of the Adjusted Consolidated EBIT compared to the value of the Adjusted Target EBIT, as per the following table:
| Adjusted Consolidated EBIT | Component B amount to be allocated | ||||
|---|---|---|---|---|---|
| Equal to or greater than 100% of the 50% Adjusted Target EBIT |
|||||
| Less than 95% of the Adjusted Target EBIT 0% |
For each year, the achievement of the MBO Performance Target will be verified, and the Component B amount calculated, on the basis of the value, respectively, of the adjusted consolidated EBITDA compared to the Adjusted Target EBITDA and the Adjusted Consolidated EBIT compared to the Adjusted Target EBIT, on approval of the consolidated financial statements for the year by the Board of Directors.
When intermediate values are achieved with respect to those indicated, the MBO amount will be determined by applying the linear interpolation method.
"Component C" refers to an amount equal to 5% of the Maximum Amount.
The Senior Executives accrue the right to the payment of Component A upon achievement of one or more specific ESG Targets.
For each financial year, the achievement of the MBO Performance Target will be verified, and the Component C amount calculated, on approval, by the Board of Directors, of the consolidated financial statements for the year.
Beneficiaries may not obtain an MBO in any amount greater than the Maximum Amount.
* * *
No deferred payment systems or ex-post correction mechanisms are envisaged.
See Section I, Paragraph 1.8.1, Sub-Paragraph "2021-2026 Stock Option Plan", of this Report.
See Section I, Paragraph 1.8.1, Sub-Paragraph "2022-2027 Stock Option Plan", of this Report.
A retention bonus of up to Euro 30,000 gross annually may be provided for Senior Executives.
Considering the nature of the bonus, which is designed to incentivize the retention of beneficiaries in the Company until December 31, 2027, if the beneficiary's employment relationship should end before that date due to resignation or any other reason beyond WIIT's

control, the beneficiary will be required to return the retention bonus portions (including by offsetting severance pay).
The pursuit of the Company's business strategy and long-term interests is ensured by the variable remuneration components set out in the Remuneration Policy and, specifically, the 2024-2026 LTI Plan, the 2021-2026 Stock Option Plan, the 2022-2027 Stock Option Plan.
Specifically, the 2024-2026 LTI Plan, which covers the three-year period 2024-2026, provides that remuneration may be paid only at the end of the plan period (i.e. after approval of the consolidated financial statements for the financial year ended December 31, 2026) on the basis of: (i) partly the achievement of economic and financial targets for the financial years 2024-2025-2026; and (ii) partly the achievement of certain values of the WIIT stock at the end of the plan period, thus orienting the beneficiaries towards strategies for the pursuit of medium-long term results.
We also note that with respect to the 2021-2026 Stock Option Plan and the 2022-2027 Stock Option Plan, (i) the payment of any remuneration in the form of Shares is intended to also link the beneficiaries' remuneration to the actual performance of WIIT stock, thus aligning the interests of the latter with those of the shareholders; and (ii) the exercise price of the Options has been set at a value higher than the market value of the Shares on approval of the plan in order to incentivize beneficiaries towards the creation of value in WIT stock in the period following the grant date of the Options.
The Company's equity-based compensation plans do not include provisions for retaining equity instruments after their acquisition.
As regards Directors who are both employees and Senior Executives, the economic treatment paid on termination of employment is regulated in accordance with and within the limits of the provisions of the national collective bargaining agreements, from time in force, applicable to the existing employee relationship, except as described below.
**
The following terms and conditions will govern the relationship between WIIT and the 2024-2026 LTI Plan MBO beneficiaries in the event of termination.
In the event that the relationship ends prior to the expiry of the performance period as a result of termination by WIT or termination by the beneficiary, unless otherwise determined by the Board of Directors, the beneficiary shall not be entitled to receive any monetary award. In such a scenario, no compensation and/or indemnity shall be payable by WIT for any damages and/or prejudice suffered by the beneficiaries.

In the event that the relationship ends after the expiry of the performance period but before the actual payment of the monetary award, the beneficiary will still be entitled to receive any monetary award accrued.
Should the relationship end due to supervening permanent disability, the Beneficiary shall retain the rights attributed, but the amount of the monetary award shall be redetermined pro rata, taking into account - and consequently reducing the amount of the monetary award - the date on which the relationship ceased.
in such an event, the monetary award, redetermined according to the pro rata criterion identified above, shall in any case be paid at the end of the performance period.
Subject to the limits and conditions established for the incentive system, the beneficiary's heirs shall be entitled to receive the monetary award redetermined by applying a pro rata criterion that will take into account - and therefore reduce the amount of the monetary award accordingly - the date on which the beneficiary's death occurred.
In such an event, the monetary award, redetermined according to the pro rata criterion identified above, shall in any case be paid at the end of the performance period.
Where the beneficiary's term of office as Director ends during the performance period for reasons other than those indicated in the preceding paragraphs, the beneficiary shall retain the rights granted in accordance with the following provisions and specifically:
Should the Beneficiary's employment relationship cease during the performance period for reasons other than those indicated above, the Beneficiary shall retain the rights granted in accordance with the provisions below and, specifically - subject to the limits and conditions established by the incentive system - the Beneficiary shall be entitled to the monetary award, but the amount shall be reduced and redetermined by applying a "pro rata" criterion taking
*

into account - and therefore reducing the amount of the monetary award accordingly - the date on which the termination of employment occurred.
**
As regards rights granted under incentive plans based on financial instruments, we note that for the 2021-2026 Stock Option Plan and the 2022-2027 Stock Option Plan, the beneficiaries will lose the right to exercise the options already granted in the event of:
Except for the cases indicated above, the beneficiaries shall retain their right to exercise the options under the terms and conditions set out in the plan regulations regardless of the events relating to their office or role by virtue of which they were designated as beneficiaries under the plans.
* *
As regards the MBO for Senior Executives, the bonus shall be paid provided that the beneficiary is an employee of the Company at the time of disbursement. Specifically, the bonus shall not be paid in the case of dismissal for just cause pursuant to Article 2119 of the Civil Code or in the case of resignation for reasons other than just cause.
Notwithstanding the foregoing, the award shall be recognized where the employment relationship is terminated due to causes beyond the control of the beneficiary as follows:
No social security or pension coverage other than mandatory coverage is provided. For information on insurance coverage other than compulsory insurance, see Section I, paragraph 1.7.
For the entire term of office of the Board of Directors, the following is provided for: (i) a gross annual remuneration to be attributed to the members of the Appointments and Remuneration Committee, in the amount of Euro 12,000 for the Chairperson and Euro 9,000 for each other member, in addition to the reimbursement of expenses incurred in the

performance of their respective functions; (ii) a gross annual remuneration to be attributed to the members of the Control, Risks and Related Parties Committee, in the amount of Euro 12,000 for the Chairperson and Euro 9,000 for each other member, in addition to the reimbursement of expenses incurred in the performance of their respective functions.
There is no specific compensation policy for Independent Directors.
Finally, the Board of Directors allocated the total annual gross remuneration awarded by the Shareholders' Meeting of May 16, 2024 as follows:
Although the Remuneration Policy was not defined using other companies as a reference, we note that overall, it is in line with the policies of other companies.
Pursuant to Article 123-ter, paragraph 3-bis, of the CFA, the Company may make exceptions to the Remuneration Policy in the event of exceptional circumstances. Such situations are understood to mean those in which a departure from the Remuneration Policy is necessary in order to pursue the long-term interests and sustainability of the Company as a whole or to ensure its ability to compete on the market. Specifically, "Exceptional Circumstances" include, but are not limited to:
(4) Alessandro Cozzi, Chief Executive Officer, is also the recipient of fixed remuneration from Group companies totaling Euro 335,000.

significant changes in the perimeter of the Company's activity during the period of . validity of the Remuneration Policy, such as the sale of a company/business unit on whose activity the performance targets of the Remuneration Policy were based, or the acquisition of a significant business not contemplated for the purposes of the preparation of the Remuneration Policy.
Such exceptions may be applied to the fixed and variable components of the remuneration of the beneficiaries of the Remuneration Policy, and include, by way of example, the vesting amounts and terms of such components and the performance targets linked to the variable components.
Any temporary exceptions to the Remuneration Policy must be approved by the Board of Directors, after consultation with the Company's Appointments and Remuneration Committee and Control, Risks and Related Parties Committee.

This Section II - prepared as per Article 123-ter, Paragraph 4, of the CFA - will be submitted for a non-binding vote of the Shareholders' Meeting called for April 29, 2025, as per Article 123ter, Paragraph 6, of the CFA. Specifically, this section - the preparation of which was subject to verification by the party appointed to carry out the legal audit (i.e., Deloitte & Touche S.p.A.) -illustrates the remuneration for the year 2024 paid to the members of the Board of Directors (i.e., the Executive and Non-Executive Directors), the members of the Board of Statutory Auditors and the Senior Executives, providing in particular the information required by Annex 3A, Schedule 7-bis, of the Issuers' Regulation. We note that no General Managers have been appointed.
No Senior Executive received higher total remuneration than the highest total remuneration awarded to members of the Board of Directors for 2024.
We note that the Board of Directors and the Board of Statutory Auditors were renewed in FY 2024 following the expiration of the terms of office of the previous corporate boards.
This section sets out each of the items that comprise remuneration for 2024, including any benefits provided in the event of termination of employment or termination of employment.
With regard to the indication of the proportion between fixed and variable remuneration, reference should be made to Table 1 at the end of this Remuneration Report.
As regards the members of the Board of Directors appointed on May 16, 2024 (all of whom were in office as of the close of FY 2024), the Company awarded the Non-Executive Directors, in addition to the reimbursement of out-of-pocket and documented expenses, the following remuneration:
As regards the members of the Board of Directors whose term expired in FY 2024, the

Company awarded the Non-Executive Directors the following remuneration, in addition to reimbursement of out-of-pocket expenses:
As regards the members of the Board of Directors appointed on May 16, 2024 (all of whom were in office as of the close of FY 2024), the Company awarded the Committee members, in addition to the reimbursement of expenses incurred in the exercise of their duties, the following remuneration:
As regards the members of the Board of Directors whose term expired in FY 2024, the Company granted the following remuneration to committee participants, in addition to reimbursement of expenses incurred in the performance of their respective duties:
The Company awarded the Non-Executive Directors the following fixed remuneration, in addition to reimbursement of out-of-pocket expenses:
(*) He also received as non-monetary remuneration the use of a car (fringe benefit totaling Euro 7,047).

Euro 260,000;
to Enrico Rampin, Chief Sales Officer, a gross annual amount of Euro 220,833, of which Euro 200,000 from the Company and Euro 20,833 from Econis AG;
In line with Section I of the 2024 Remuneration Report, the Company paid the following variable remuneration to Executive Directors in 2024:
Finally, with reference to the 2024-2026 LTI Plan, we note that, in line with the rules set out by the Company's Remuneration Policy on long-term incentives, no compensation was paid to the beneficiaries as it is envisaged that any payment of such compensation will be deferred until after the approval of the 2026 consolidated financial statements.
The pay mix of Executive Directors was therefore as follows:
The following non-monetary compensation was provided:


As regards the standing members of the Board of Statutory Auditors appointed on May 16, 2024 (all of whom were in office at the close of FY 2024), the following remuneration was paid to the standing members of the Board:
As regards the standing members of the Board of Statutory Auditors leaving office in FY 2024, the following remuneration was paid to the standing members of the Board:
Gross fixed remuneration paid to Senior Executives totaled Euro 358,447, of which Euro 248,446 attributable to Non-Executive Directors (and Senior Executives) Stefano Pasotto (who left the office of Director on May 16, 2024) and Chiara Grossi.
Gross variable monetary remuneration paid to Senior Executives totaled Euro 164,280, of which Euro 95,191 attributable to Non-Executive Directors (and Senior Executives) Stefano Pasotto (whose term as Director ended on May 16, 2024) and Chiara Grossi.
The Company granted the Senior Executives the following non-monetary benefits for a total of Euro 98,190 (of which Euro 55,358 attributable to Non-Executive Directors [and Senior Executives] Stefano Pasotto [who left the office of Director on May 16, 2024] and Chiara Grossi): (i) a company car for mixed use; (ii) an insurance policy with a leading insurance company covering permanent disability and accidents, including due to illness, with a survivor's benefit in favor of the Executive's family; (iii) a reimbursement health insurance policy, including a complete annual check-up and dental and specialist expenses, as envisaged under the "Marketing Managers" National Collective Bargaining Agreement; (iv) reimbursement of school expenses; (v) housing expenses for residential use in Milan, where the Company is based.
No indemnities and/or other benefits for termination of office or termination of employment were allocated.

The Company did not make exceptions to the Remuneration Policy.
Ex-post adjustment mechanisms for the variable component (malus or clawback of variable remuneration) were not applied.
Comparative information is provided below for 2020, 2021, 2023 and 2024, regarding the annual changes in:

| Name | Office | Year | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2021 | 2020 | ||||||
| Absolute value (Euro) |
% change on previous year |
Absolute value (Euro) |
% change on previous year |
Absolute value (Euro) |
% change on previous year |
Absolute value (Euro) |
% change on previous year |
Absolute value (Euro) |
||
| IN OFFICE | ||||||||||
| Enrico Giacomelli |
Chairperson of the Board of Directors | 36,250 | 100.00% | |||||||
| Alessandro Cozzi |
Chief Executive Officer | 781,438 | 8.99% | 716,916 | -10% | 794,188 | -13% | 912,205 | 51% | 602,546 |
| Enrico Rampin | Chief Sales Officer | 612,084 | 2.85% | 595,117 | 42% | 418,822 | -14% | 488,321 | 97% | 247,879 |
| Francesco Baroncelli |
Chief Mergers & Acquisition Officer | 610,320 | 3.46% | 589,873 | 26% | 469,225 | -14% | 544,791 | 103% | 268,514 |
| Di Annamaria Ruscio |
Independent Director | 36,000 | 0.00% | 36,000 | 0% | 36,000 | 50% | 24,000 | 0% | 24,000 |
| Emanuela Basso Petrino |
Independent Director | 27,000 | 0.00% | 27,000 | 0% | 27,000 | 50% | 18,000 | - | |
| Nathalie Brazzelli(*) |
Independent Director | 24,000 | 0.00% | 24,000 | 0% | 24,000 | 50% | 16,000 | 12,000(*) | |
| Chiara Grossi | Non-Executive Director Senior (and Executive) |
284,828 | 6.68% | 266,976 | 70% | 157,410 | ||||
| Santino Saguto | Independent Director | 9375 | 100.00% | - | ||||||
| Vieri Chimenti | Chairperson of the Board of Statutory Auditors |
18770.49 | 100.00% | - | - | |||||
| Paolo Ripamonti |
Statutory Auditor (formerly Chairperson of the Board of Statutory Auditors until May 16, 2024) |
19,250 | 6.94% | 18,000 | 0% | 18,000 | 8% | 16,650 | 39% | 12,000 |
| Chiara Olliveri Siccardi |
Statutory Auditor | 17,004 | 41.70% | 12,000 | 0% | 12,000 | 50% | 8,000 | - |

| LEFT OFFICE | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Riccardo Sciutto |
Chairperson of the Board of Directors | 21,750 | -70.41% | 27% | 58,000 | 50% | 7% | 36,000 | |||
| Stefano Pasotto |
Non-Executive Director (and Senior Executive) |
162,923 | -9.84% | 180,707 | 100% | - | - | - | - | ||
| Francis De Zanche |
Statutory Auditor | 5,000 | -58.33% | 12,000 | 0% | 12,000 | 50% | 8,000 | - | - |
(*) In 2020, Nathalie Brazzelli received an annual fee of Euro 12,000 but in relation to her position as Statutory Auditor.
| Performance indicator |
Year | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2021 | 2020 | ||||||||
| Absolute value (Euro millions) |
% change on previous year |
Absolute value (Euro millions) |
% change on previous year |
Absolute value (Euro millions) |
% change on previous year |
Absolute value (Euro millions) |
% change on previous year |
Absolute value (Euro millions) |
||||
| Adjusted revenues | 61.6 | 6% | 58.3 | 9% | 53.2 | 85% | 29 | 12% | 25.7 | |||
| Adjusted EBITDA | 27.7 | 5% | 26.3 | 24% | 21.2 | 71% | 12 | 13% | ||||
| Adjusted EBIT | 11.5 | -90% | 12.7 | 25% | 10.2 | 149% | 2% | |||||
| Adjusted Net Profit | 3.6 | -62% | 9.7 | 46% | 6.6 | 182% | 2 | -64% | 6.5 |
NE: We note that (j the meger of Adelante S.p.A., and Easte in 2022; and the menger of Entern Sp.A., into WIT was frailied in 2003, so the restlis in 1203, so the esse and to

| Performance indicator | Year | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||||||
| Absolute value (Euro millions) |
% change on previous year |
Absolute value (Euro millions) |
% change on previous year |
Absolute value (Euro millions) |
% change on previous year |
Absolute value (Euro millions) |
% change on previous year |
Absolute value (Euro millions) |
|||||
| Consolidated adjusted revenues |
158.6 | 22% | 130.1 | 10% | 118.8 | 54% | 77 | 47% | 52.5 | ||||
| Adjusted consolidated EBITDA |
28 | 14% | 50.8 | 20% | 42.2 | 41% | 30 | 63% | 18.3 | ||||
| Adjusted Consolidated EBIT |
29 | 4% | 28.0 | 21% | 23.2 | 48% | 16 | 74% | ರಿ | ||||
| Adjusted Consolidated profit |
14.7 | -3% | 15.1 | 21% | 12.5 | 36% | ರಿ | 50% | 6.1 |
(ii) average gross annual remuneration full-time employees, of WIT employees other than those whose remuneration is represented in this section II of the Remuneration Report
| Performance indicator | Year | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2021 | ||||||||
| Absolute value (Euro) |
% change on previous year |
Absolute value (Euro) |
% change on previous year |
Absolute value (Euro) |
% change on previous year |
Absolute value (Euro) |
% change on previous year |
Absolute value (Euro) |
|||
| Average gross annual remuneration of full- time WIIT employees |
44,657 (*) | 10.27% | 40,498 (*) | 2.99% | 39,324(*) | 6.26% | 37,006(*) | 3.18% | 35,864(*) |
(*) This value does not take into account any variable remuneration paid.

In accordance with the provisions of Article 123-ter, paragraph 6 of the CFA, the Shareholders' Meeting of May 16, 2024 cast a non-binding vote on Section II of the 2024 Remuneration Report. Votes in favor totaled 71.348661% of the total voting rights and 90.873382% of the total voting rights present.

TABLE 1: Remuneration of the Board of Directors, Board of Statutory Auditors, and Senior Executives
| (A) | (B) | (C) | (D) | 1 | 2 | 3 | ব | 5 | 6 | 7 | 8 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period of | Fixed remuneratio n |
Remuneration for committee participation |
Non-equity variable remuneration |
Non- | Other | Fair Value of equity |
Benefits on | |||||
| Name | Office | office | Concl. of office | Bonuses and other incentives |
Profit sharing |
monetary benefits |
remunerati on |
Total | remunerati on |
conclusion of office |
||
| MEMBERS OF THE BOARD OF DIRECTORS IN OFFICE | ||||||||||||
| Enrico Giacomelli | Chairperson | 16/05/2024 - 31/12/2024 |
Appr. 2026 Annual Accounts |
25,000 | 11,250 | 36,250 | ||||||
| Alessandro Cozzi | Chief Executive Officer |
01/01/2024 – 31/12/2024 |
Appr. 2026 Annual Accounts |
|||||||||
| (I) Remuneration from company preparing the accounts | 294,096 | 165,467 | 781,438 | |||||||||
| (II) Remuneration from subsidiaries and associated companies | 320,833 | 320,833 | ||||||||||
| (III) Total | 642,708 | 294,096 | 165,467 | 1,102,271 | ||||||||
| Enrico Rampin | Chief Sales Officer |
01/01/2024 – 31/12/2024 |
Appr. 2026 Annual Accounts |
|||||||||
| (I) Remuneration from company preparing the accounts | 200,000 | 296,064 | 116,020 | 612,084 | ||||||||
| (II) Remuneration from subsidiaries and associated companies | 20,833 | 20,833 | ||||||||||
| (III) Total | 296,064 | 116,020 | 632,917 | |||||||||
| Francesco Baroncelli | Chief Mergers & Acquisition Officer |
01/01/2024 - 31/12/2024 |
Appr. 2026 Annual Accounts |
|||||||||
| (I) Remuneration from company preparing the accounts | 260,000 | 296,064 | 54,256 | 610,320 | ||||||||
| (II) Remuneration from subsidiaries and associated companies | 50,000(*) | 50,000 |

| (A) | (B) | (C) | (D) | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Office | Period of | Fixed | Remuneration for committee participation |
Non-equity variable remuneration |
Non- | Other | Total | Fair Value of equity |
Benefits on | |||
| Name | office | Concl. of office | remuneratio n |
Bonuses and other incentives |
Profit sharing |
monetary benefits |
remunerati on |
remunerati on |
conclusion of office |
|||
| (III) Total | 260,000 | 296,064 | 54,256 | 50,000 | 660,320 | |||||||
| Annamaria Di Ruscio | Independent Director |
01/01/2024 – 31/12/2024 |
Appr. 2026 Annual Accounts |
15,000 | 21,000 | 36,000 | ||||||
| Emanuela Basso Petrino | Independent Director |
01/01/2024 - 31/12/2024 |
Appr. 2026 Annual Accounts |
15,000 | 12,000 | 27,000 | ||||||
| Nathalie Brazzelli | Independent Director |
01/01/2024 – 31/12/2024 |
Appr. 2026 Annual Accounts |
15,000 | 9,000 | 24,000 | ||||||
| Chiara Grossi | Director (and Senior Executive) |
01/01/2024 – 31/12/2024 |
Appr. 2026 Annual Accounts |
|||||||||
| (I) Remuneration from company preparing the accounts | 153,440(**) | 79,885 | 39,487 | 12,016 | 284,828 | |||||||
| (II) Remuneration from subsidiaries and associated companies | 6,250 | 6,250 | ||||||||||
| (III) Total | 159,690 | 79,885 | 39,487 | 12,016 | 291,078 | |||||||
| Santino Saguto | Independent Director |
16/05/2024 - 31/12/2024 |
Appr. 2026 Annual Accounts |
9,375 | 9,375 | |||||||
| MEMBERS OF THE BOARD OF DIRECTORS LEAVING OFFICE DURING THE YEAR | ||||||||||||
| Riccardo Sciutto | Chairperson | 01/01/2024 – 16/05/2024 |
Appr. 2023 Annual Accounts |
14,500 | 7,250 | 21,750 | ||||||
| Stefano Pasotto | Director | 01/01/2024 - 16/05/2024 |
Appr. 2023 Annual Accounts |

| (A) | (B) | (C) | (D) | ו | 2 | 3 | 4 | 5 | e | 7 | 8 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period of | Fixed | Remuneration | Non-equity variable remuneration |
Non- | Other | Fair Value of equity |
Benefits on | |||||
| Name | Office | office | Concl. of office | remuneratio m |
for committee participation |
Bonuses and other incentives |
Profit sharing |
monetary benefits |
remunerati on |
Total | remunerati on |
conclusion of office |
| (and Senior Executive) |
||||||||||||
| (I) Remuneration from company preparing the accounts | 125,006(***) | 15,306 | 15,871 | 6,740 | 162,923 | |||||||
| (II) Remuneration from subsidiaries and associated companies | 6,250 | 6,250 | ||||||||||
| (III) Total | 131,256 | 15,306 | 15,871 | 6,740 | 169,173 | |||||||
| MEMBERS OF THE BOARD OF STATUTORY AUDITORS | ||||||||||||
| Vieri Chimenti | Chairperson of the Board of Statutory Auditors |
16/05/2024 – 31/12/2024 |
Appr. 2026 Annual Accounts |
18,770 | 18,770 | |||||||
| Paolo Ripamonti | Statutory Auditor (formerly Chairperson of the 01/01/2024 - Board of Statutory 31/12/2024 Auditors until 16/5/2024) |
Appr. 2026 Annual Accounts |
19,250 | 19,250 | ||||||||
| Chiara Olliveri Siccardi | Statutory Auditor | 01/01/2024 - 31/12/2024 |
Appr. 2026 Annual Accounts |
17,004 | 17,004 | |||||||
| MEMBERS OF THE BOARD OF STATUTORY AUDITORS DURING THE YEAR | ||||||||||||
| Francis De Zanche | Statutory Auditor | 01/01/2024 – 16/05/2024 |
Appr. 2023 Annual Accounts |
5,000 | 5,000 | |||||||
| SENIOR EXECUTIVES EXCLUDING THOSE THAT ARE ALSO DIRECTORS (***) | ||||||||||||
| Number of Senior Executives: 1 | 110,000 | 69,090 | 42,832 | 6,740 | 228,662 | |||||||
| SENIOR EXECUTIVES INCLUDING THOSE THAT ARE ALSO DIRECTORS (***) |

| (A) | (B) | (C) | D) | ম | 8 | g | o | 8 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Office | Period of | Concl. of office remuneratio for committee | Fixed | Remuneration | Non-equity variable remuneration |
Non- | Other remunerati |
Total | Fair Value of equity |
Benefits on conclusion |
|
| office | n | participation | Bonuses and other incentives |
Profit sharing |
monetary benefits |
on | remunerati on |
of office | ||||
| Number of Senior Executives: 3 | 358,447 | 164,280 | 98,190 | 25,496 | 646,413 |
NB: values expressed in Euro.
AD France and Book and Euro Isa.
(*) In the oapacity of Jotegration Manager of Econis AQ.
(*) In the oapacity of Jotegration and Euro 138,440 as an Executive.
(***) Of which

| Options held at beginning of the year | Options granted in the year | Options exercised in the year | Options expiring in |
Options held at the end of |
Options accruing in |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| the year | the year | the year | |||||||||||||||
| A | B | (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | (11) | (12) | (13) | (14) | (15) = (2)+(5)- (11)-(14) |
(16) |
| Name | Office | Plan | Number of options |
Exercise price |
Possible exercise period (from-to) |
Number of options |
Exercise price |
Possible exercise period (from- to) |
Fair value at grant date |
Grant date | Market price of the underlying shares at the grant date |
Number of options |
Exercise price |
Market price of the underlying shares at the exercise date |
Number of options |
Number of options |
Fair value |
| Riccardo Sciutto(*) |
Chairperson | 2022-2027 Stock Option Plan (21.04.2022) |
25,000 | € 40 | From 01.07.27 to 01.07.28 |
25,000 | |||||||||||
| Options held at beginning of the year | Options granted in the year | Options exercised in the year | Options expiring in the year |
Options held at the end of the year |
Options accruing in the year |
||||||||||||
| A | B | (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | (11) | (12) | (13) | (14) | (15) = (2)+(5)- (11)-(14) |
(16) |
| Name | Office | Plan | Number of options |
Exercise price |
Possible exercise period (from- to) |
Number of options |
Exercise price |
Possible exercise period (from - to) |
Fair value at grant date |
Grant date | Market price of the underlying shares at the grant date |
Number of options |
Exercise price |
Market price the of underlying shares at the exercise date |
Number of options |
Number of options |
Fair value |
| Francesco Baroncelli |
Chief Mergers & Acquisition Officer |
2021-2026 Stock Option Plan (05.05.2021) |
280,000 | € 18 | 50% from 01.07.24 to 01.07.27 100% from 01.07.26 to |
- | 280,000 | ||||||||||
| 01.07.27 | |||||||||||||||||
| Options held at beginning of the year | Options granted in the year | Options exercised in the year | Options expiring in the year |
Options held at the end of the year |
Options accruing in the year |
||||||||||||
| A | B | (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | (11) | (12) | (13) | (14) | (15) = (2)+(5)- (11)-(14) |
(16) |
| Name | Office | Plan | Number of options |
Exercise price |
Possible exercise period (from- to) |
Number of options |
Exercise price |
Possible exercise period (from - to) |
Fair value at grant date |
Grant date | Market price of the underlying shares at the grant date |
Number of options |
Exercise price |
Market price the of underlying shares at the exercise date |
Number of options |
Number of options |
Fair value |
| 3 Senior Executives | 2021-2026 Stock |
80,000(**) | € 18 | 50% from 01.07.24 to |
- | - | - | 80,000(**) |

| Option Plan | 01.07.27 | |||||
|---|---|---|---|---|---|---|
| (05.05.2021) | ||||||
| 100% from | ||||||
| 01.07.26 to | ||||||
| 01.07.27 | ||||||
NB: No member of the Board of Directors and no Senior Executive received remuneration from subsidiaries or associates.
(*) Left office on May 16, 2024.
(**) Of which 30,000 are held by Chiara Grossi and 30,000 are held by Stefano Pasotto.

| ব | B | (1) | (2) | (3) | (4) | ||||
|---|---|---|---|---|---|---|---|---|---|
| Name | Office | Plan | Bonus for the year | Prior year bonuses | Other bonuses | ||||
| (A) | (B) | (C) | (A) | (B) | (C) | ||||
| Alessandro Cozzi | Chief Executive Officer |
lssuable/Issued | Deferred | Period of deferment | No longer issuable | lssuable/Issued | Still deferred | ||
| (I) Remuneration from company preparing the accounts |
Annual MBQ | 294,096 | |||||||
| (II) Remuneration from subsidiaries and associated companies |
|||||||||
| (III) Total | Annual MBO | 294,096 | |||||||
| ( | B | (1) | (2) | (3) | (4) | ||||
| Name | Office | Plan | Bonus for the year | Prior year bonuses | Other bonuses | ||||
| (A) | (B) | (C) | (A) | (B) | (C) | ||||
| Enrico Rampin | Chief Sales Officer | lssuable/Issued | Deferred | Period of deferment | No longer issuable | lssuable/Issued | Still deferred | ||
| (I) Remuneration from company preparing the accounts |
Annual MBO | 296,064 | |||||||
| (II) Remuneration from subsidiaries and associated companies |
|||||||||
| (III) Total | Annual MBO | 296,064 | |||||||
| A | B | (1) | (2) | (3) | (4) | ||||
| Name | Office | Plan | Bonus for the year | Prior year bonuses | Other bonuses | ||||
| (A) | (B) | (C) | (A) | (B) | (C) | ||||
| Francesco Baroncelli | Chief Mergers & Acquisition Officer |
lssuable/Issued | Deferred | Period of deferment | No longer issuable | lssuable/Issued | Still deferred |

| (I) Remuneration from company preparing the accounts |
Annual MBQ | 296,064 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| (II) Remuneration from subsidiaries and associated companies |
|||||||||
| (III) Total | Annual MBQ | 296,064 | |||||||
| Senior Executives | Office | Plan | Bonus for the year | Prior year bonuses | Other bonuses | ||||
| (A) | (B) | (C) | (A) | (B) | (C) | ||||
| lssuable/Issued | Deferred | Period of deferment | No longer issuable | Issuable/Issued | Still deferred | ||||
| (I) Remuneration from company preparing the accounts |
Annual MBQ | 164,280(*) | |||||||
| (II) Remuneration from subsidiaries and associated companies |
(*) Of which, Euro 79,885 attributable to Chiara Grossi and Euro 15,306 to Stefano Pasotto.

| NAME | OFFICE | COMPANY | NUMBER OF SHARES HELD AT 31.12.2023 DATE OF APPOINTMENT |
NUMBER OF SHARES PURCHASED |
NUMBER OF SHARES SOLD |
NUMBER OF SHARES HELD AT 31.12.2024 / DATE OF DEPARTURE |
||
|---|---|---|---|---|---|---|---|---|
| DIRECTORS & STATUTORY AUDITORS | ||||||||
| Enrico Giacomelli | Chairperson | WIIT S.p.A. | 6,250 | 6,250 | ||||
| Alessandro Cozzi(*) | Chief Executive Officer | WIIT S.p.A. | 15,822,202 | 925,000 | 391,302 | 16,355,900 | ||
| Enrico Rampin(*) | Chief Sales Officer | WIIT S.p.A. | 545,630 | 545,630 | ||||
| Francesco Baroncelli(*) | Chief Mergers & Acquisition Officer | WIIT S.p.A. | 425,760 | 425,760 | ||||
| Annamaria Di Ruscio | Independent Director | WIIT S.p.A. | 1,340 | 1,340 | ||||
| Emanuela Basso Petrino | Independent Director | WIIT S.p.A. | ||||||
| Nathalie Brazzelli | Independent Director | WIIT S.p.A. | ||||||
| Chiara Grossi | Director (and Senior Executive) | WIT S.p.A. | 27,500 | 27,500 | ||||
| Santino Saguto | Independent Director | WIIT S.p.A. | ||||||
| Vieri Chimenti | Chairperson of the Board of Statutory Auditors |
WIIT S.p.A. | ||||||
| Paolo Ripamonti | Statutory Auditor | WIIT S.p.A. |

| Chiara Olliveri Siccardi | Statutory Auditor | WIIT S.p.A. | I | - | - | |||
|---|---|---|---|---|---|---|---|---|
| DIRECTORS AND STATUTORY AUDITORS LEAVING OFFICE DURING THE YEAR | ||||||||
| Riccardo Sciutto(*) | Chairperson | WIIT S.p.A. | 47,540 | - | 47,540 | |||
| Stefano Pasotto | Director (and Senior Executive) | WIIT S.p.A. | 15,150 | - | - | 15,150 | ||
| Francis De Zanche | Statutory Auditor | WIIT S.p.A. | 1,250 | - | 1,250 |
(*) Directly and indirectly.

| NUMBER OF SENIOR EXECUTIVES |
COMPANY | NUMBER OF SHARES HELD NUMBER OF SHARES AT 31.12.2023 |
PURCHASED | NUMBER OF SHARES SOLD NUMBER OF SHARES HELD AT 31.12.2024 |
|---|---|---|---|---|
| WIIT S.p.A. | 15.188 | 183 | 15.371 |
NB: For information on the holdings of Senior Executives Stefano Pasotto and Chiara Grossi, see Table 1 above.
* * *
For the Board of Directors
The Chairperson
Enrico Giacomelli
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.